1.2M doses of China-made vaccine arrive in Indonesia

Indonesia's government said 1.2 million doses of a COVID-19 vaccine developed by China-based biopharmaceutical company Sinovac Biotech arrived in the country late Sunday. President Joko Widodo said that another 1.8 million doses of the vaccine are expected to arrive in early January. He urged people to listen to authorities' instructions on getting vaccinated, as the roll-out will be staggered. 

The government is still waiting for millions of other doses of the Sinovac vaccine to arrive in the form of raw materials that will be further processed by state-owned pharmaceutical holding company PT Bio Farma. Indonesia is already cooperating with Sinovac in phase 3 clinical trials of its vaccine candidate, with tests being carried out on 1,620 volunteers in West Java's Bandung city since August.